Assistant Professor in the Liver Cancer Program (Icahn School of Medicine at Mount Sinai, New York). ILCA Executive Secretary.
Assistant Professor in the Liver Cancer Program (Icahn School of Medicine at Mount Sinai, New York). He received his medical degree from the University of Santiago de Compostela (Spain), and he is board certified in Gastroenterology and Hepatology (Spain). In 2008 he obtained his PhD and received the Sheila Sherlock Fellowship from EASL to join the Liver Cancer Translational Research Laboratory of the BCLC Group, Barcelona (Spain). In 2010, he became the Scientific Manager of the HEPTROMIC consortium, a research initiative funded by the European Commission dedicated to identifying genomic prognostic predictors and oncogenic drivers in HCC. In 2013, he joined the Institute of Liver Studies at King’s College (London), as a Senior Lecturer and Consultant Hepatologist where he served as co-leader of the HCC Clinic and Multidisciplinary Tumor Board. In 2014 he started his position at the Icahn School of Medicine at Mount Sinai with the aim of developing novel minimally invasive biomarkers using liquid biopsy and studying the impact of intratumor heterogeneity in precision medicine. He has more than 90 publications (>8,000 citations, H-index 40) including articles in N Engl J Med, Nat Genet, Nat Biotech, Gastroenterology, Hepatology, J Hepatol, J Clin Invest, Oncogene, etc. He wrote more than 15 book chapters and edited a book on resistance to targeted therapies in HCC. He serves as Associate Editor for Liver Cancer and Journal of Hepatology.
Symposium 1 - The Cell of Origin of Liver Cancer
Back to the Search
1230 East Boston Central Drive Dallas, TX 75251
Register as attendee
Become and exhibitor
View conference sessions
View exhibit hall
Copyright 2018, a2z, Inc. All rights reserved.